Literature DB >> 35254917

CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?

Dimitri J Maamari1,2, Farouc A Jaffer3,4,5, Amit V Khera1,3,5,2, Akl C Fahed1,3,4,5,2.   

Abstract

Entities:  

Keywords:  anticoagulants; cytochrome P-450 CYP2C19; pharmacogenetics; precision medicine

Mesh：

Substances：

Year:  2022        PMID： 35254917      PMCID： PMC8909924          DOI： 10.1161/CIRCULATIONAHA.121.057028

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.

Authors:  Shoichi Kuramitsu; Masanobu Ohya; Tomohiro Shinozaki; Hiromasa Otake; Kazunori Horie; Hiroyoshi Kawamoto; Futoshi Yamanaka; Masahiro Natsuaki; Hiroki Shiomi; Gaku Nakazawa; Kenji Ando; Kazushige Kadota; Shigeru Saito; Takeshi Kimura
Journal:  Circ Cardiovasc Interv       Date:  2019-06-10       Impact factor: 6.546

Review 2.  Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.

Authors:  S A Scott; K Sangkuhl; E E Gardner; C M Stein; J-S Hulot; J A Johnson; D M Roden; T E Klein; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2011-06-29       Impact factor: 6.875

3.  Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.

Authors:  Naveen L Pereira; Michael E Farkouh; Derek So; Ryan Lennon; Nancy Geller; Verghese Mathew; Malcolm Bell; Jang-Ho Bae; Myung Ho Jeong; Ivan Chavez; Paul Gordon; J Dawn Abbott; Charles Cagin; Linnea Baudhuin; Yi-Ping Fu; Shaun G Goodman; Ahmed Hasan; Erin Iturriaga; Amir Lerman; Mandeep Sidhu; Jean-Francois Tanguay; Liewei Wang; Richard Weinshilboum; Robert Welsh; Yves Rosenberg; Kent Bailey; Charanjit Rihal
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

Review 4.  Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.

Authors:  Dominick J Angiolillo; Deepak L Bhatt; Christopher P Cannon; John W Eikelboom; C Michael Gibson; Shaun G Goodman; Christopher B Granger; David R Holmes; Renato D Lopes; Roxana Mehran; David J Moliterno; Matthew J Price; Jacqueline Saw; Jean-Francois Tanguay; David P Faxon
Journal:  Circulation       Date:  2021-02-08       Impact factor: 29.690

5.  Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Eric A Secemsky; Neel M Butala; Uri Kartoun; Sadiqa Mahmood; Jason H Wasfy; Kevin F Kennedy; Stanley Y Shaw; Robert W Yeh
Journal:  J Am Heart Assoc       Date:  2016-10-17       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.